To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

NCT00659750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

418

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: Ciclesonide
DRUG: Placebo

Sponsor

AstraZeneca